News | October 09, 2023
Mitsui invests in Lokavant Holdings
Lokavant provides clinical trial intelligence
Lokavant provides clinical trial intelligence
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The Main campaign started from October 2
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Subscribe To Our Newsletter & Stay Updated
